MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The Centers for Disease Control and Prevention has added new resources for health care providers to its Be Ready for Measles Toolkit. They include a decision…
Headline
The Medicare Payment Advisory Commission June 13 released its June report to Congress that outlines recommendations for hospital and other Medicare payment…
Headline
The departments of Health and Human Services, Labor, and the Treasury have certified two more independent dispute resolution entities, bringing the total…
Headline
Data from the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill shows that health care cuts under…
Headline
The Joint Commission June 11 announced a new partnership with the Coalition for Health AI to help accelerate the development and adoption of best practices and…
Headline
The Alliance for Innovation on Maternal Health, with support from the Health Resources and Services Administration, will host a five-part learning series…